HER2-Low Breast Cancer | Oncology Today with Dr Neil Love: Optimizing the Identification of HER2-Low Breast Cancer

Featuring an interview with Dr Kimberly H Allison, including the following topics:

Contemporary practices in pathology and reporting biomarkers of interest (0:00)

HER2 testing across numerous solid tumor types (2:47)

ER-low reporting category and pathologic interpretation (6:28)

PD-1/PD-L1 testing methodology and challenges with bone biopsies (10:53)

CME information and select publications

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.